Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 10.27B 1.52B 1.31B 1.21B 1.13B 2.12B 144B 2.15B 14.27B 5.56B 70.23B 5.7B 5.58B 243B P/E Ratio 2026 *
15.3x
P/E Ratio 2027 * 12.7x
Enterprise Value 10.27B 1.52B 1.31B 1.21B 1.13B 2.12B 144B 2.15B 14.27B 5.56B 70.23B 5.7B 5.58B 243B EV / Sales 2026 *
2.38x
EV / Sales 2027 * 2.16x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day+2.19%
1 week+2.19%
Current month-1.49%
1 month-8.63%
3 months-9.56%
6 months-16.68%
Current year-14.89%
1 week 23.17
Extreme 23.17
24.3
1 month 23.09
Extreme 23.09
26.28
Current year 23.09
Extreme 23.09
29.22
1 year 23.09
Extreme 23.09
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.54
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
+2.19%+2.19%-18.22%-18.31% 1.48B
-2.41%+0.69%+40.12%+154.01% 1,035B
+1.07%+5.57%+55.14%+50.53% 574B
+1.32%+1.24%+18.92%+64.81% 397B
+0.77%+0.77%+21.19%+15.95% 324B
-0.85%-0.68%+23.44%+14.94% 281B
+0.44%+5.39%+25.86%+35.39% 278B
+1.66%+1.20%-44.41%-47.37% 193B
+0.32%+2.78%+21.72%+62.37% 191B
-0.22%-2.78%+14.90%+60.77% 156B
Average +0.08%+1.22%+15.87%+39.31% 343.14B
Weighted average by Cap. -0.74%+1.29%+28.91%+71.58%

Financials

2026 *2027 *
Net sales 4.32B 638M 551M 508M 475M 891M 60.65B 905M 6B 2.34B 29.52B 2.39B 2.34B 102B 4.75B 703M 607M 559M 523M 981M 66.78B 996M 6.6B 2.57B 32.5B 2.64B 2.58B 113B
Net income 674M 99.6M 86.03M 79.27M 74.2M 139M 9.47B 141M 936M 365M 4.61B 374M 366M 15.96B 745M 110M 95.09M 87.62M 82.02M 154M 10.46B 156M 1.03B 403M 5.09B 413M 404M 17.64B
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
12/06/26 23.83 ¥ +2.19% 4,728,634
11/06/26 23.32 ¥ -1.31% 3,070,599
10/06/26 23.63 ¥ +1.33% 2,887,942
09/06/26 23.32 ¥ -0.34% 2,901,650
08/06/26 23.40 ¥ -2.50% 4,321,409
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.83CNY
Average target price
36.25CNY
Spread / Average Target
+52.12%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!